This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LACQ vs. ELYM, AADI, ATNM, NBRV, PYRGF, LNAI, TAOX, NNVC, EGRX, and IBIOShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include Eliem Therapeutics (ELYM), Aadi Bioscience (AADI), Actinium Pharmaceuticals (ATNM), Nabriva Therapeutics (NBRV), PyroGenesis Canada (PYRGF), Lunai Bioworks (LNAI), Synaptogenix (TAOX), NanoViricides (NNVC), Eagle Pharmaceuticals (EGRX), and iBio (IBIO). Leisure Acquisition vs. Its Competitors Eliem Therapeutics Aadi Bioscience Actinium Pharmaceuticals Nabriva Therapeutics PyroGenesis Canada Lunai Bioworks Synaptogenix NanoViricides Eagle Pharmaceuticals iBio Eliem Therapeutics (NASDAQ:ELYM) and Leisure Acquisition (NASDAQ:LACQ) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Is ELYM or LACQ more profitable? Leisure Acquisition's return on equity of 30.17% beat Eliem Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Eliem TherapeuticsN/A -47.03% -45.97% Leisure Acquisition N/A 30.17%6.14% Which has better earnings & valuation, ELYM or LACQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEliem TherapeuticsN/AN/A-$35.12M-$0.53-3.68Leisure AcquisitionN/AN/A$4.31MN/AN/A Do institutionals and insiders have more ownership in ELYM or LACQ? 69.8% of Eliem Therapeutics shares are held by institutional investors. Comparatively, 56.7% of Leisure Acquisition shares are held by institutional investors. 4.7% of Eliem Therapeutics shares are held by company insiders. Comparatively, 39.6% of Leisure Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to ELYM or LACQ? In the previous week, Eliem Therapeutics' average media sentiment score of 0.00 beat Leisure Acquisition's score of -1.38 indicating that Eliem Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Eliem Therapeutics Neutral Leisure Acquisition Negative Which has more risk and volatility, ELYM or LACQ? Eliem Therapeutics has a beta of -0.39, indicating that its share price is 139% less volatile than the S&P 500. Comparatively, Leisure Acquisition has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500. SummaryLeisure Acquisition beats Eliem Therapeutics on 5 of the 7 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LACQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$16.00M$1.01B$2.48B$10.51BDividend YieldN/A4.84%13.84%4.81%P/E RatioN/A1.2526.1227.09Price / SalesN/A29.977,134.58131.82Price / Cash20.0317.6359.9861.22Price / Book-13.538.033.336.52Net Income$4.31M-$7.71M-$445.27M$276.75M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$2.57+4.0%N/A+1,366.7%$16.00MN/A0.00N/ANegative NewsHigh Trading VolumeELYMEliem TherapeuticsN/A$1.80+9.1%N/A-64.3%$53.55MN/A-3.409Gap UpAADIAadi BioscienceN/A$2.13-4.1%N/A-1.9%$52.61M$25.07M-0.9340Gap UpATNMActinium Pharmaceuticals2.1945 of 5 stars$1.50-2.6%$4.50+200.0%-13.1%$46.79MN/A-1.0830NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070PYRGFPyroGenesis Canada0.4727 of 5 stars$0.20+3.0%N/A-66.9%$36.57M$9.14M-3.2590News CoverageHigh Trading VolumeLNAILunai BioworksN/A$1.24flatN/AN/A$28.74MN/A-0.1620News CoverageTAOXSynaptogenix0.0562 of 5 stars$7.09-7.3%N/AN/A$26.68MN/A-0.354Gap UpNNVCNanoViricides0.7572 of 5 stars$1.43-0.3%N/A-4.0%$24.84MN/A-1.9820News CoverageShort Interest ↓EGRXEagle Pharmaceuticals2.2594 of 5 stars$1.60-46.7%N/A+87.5%$20.78M$257.55M0.00100High Trading VolumeIBIOiBio2.0694 of 5 stars$0.85-1.4%$5.00+485.5%-70.3%$16.79M$400K-0.49100News CoverageAnalyst Forecast Related Companies and Tools Related Companies ELYM Alternatives AADI Alternatives ATNM Alternatives NBRV Alternatives PYRGF Alternatives LNAI Alternatives TAOX Alternatives NNVC Alternatives EGRX Alternatives IBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LACQ) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
